These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 13443966)
1. In vitro study of a mouse mammary carcinoma simulating carsinosarcoma and sarcomatous overgrowth during transplantation. RINGSTED J Acta Pathol Microbiol Scand; 1957; 40(5):373-83. PubMed ID: 13443966 [No Abstract] [Full Text] [Related]
2. Effects of roentgen irradiation on the tumor bed. III. The different inhibiting action on the growth of mouse mammary carcinoma resulting from pre- or post-transplantation irradiation. VERMUND H; STENSTROM KW; MOSSER DG; LOKEN MK Radiat Res; 1958 Jan; 8(1):22-31. PubMed ID: 13506031 [No Abstract] [Full Text] [Related]
3. Sarcomatous change and maintenance of differentiation in long-term cultures of mouse mammary carcinoma. SANFORD KK; DUNN TB; WESTFALL BB; COVALESKY AB; DUPREE LT; EARLE WR J Natl Cancer Inst; 1961 May; 26():1139-83. PubMed ID: 13746235 [No Abstract] [Full Text] [Related]
4. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma. Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864 [TBL] [Abstract][Full Text] [Related]
5. [Effect of spreading factors on the development of mouse mammary carcinoma]. LACASSAGNE A; LOISELEUR J; RUDALI G Bull Assoc Fr Etud Cancer; 1957 Dec; 44(4):552-72. PubMed ID: 13523265 [No Abstract] [Full Text] [Related]
6. [Blood supply of mouse mammary carcinoma during the developmental process]. NATADZE TG Vopr Onkol; 1958; 4(3):292-5. PubMed ID: 13604035 [No Abstract] [Full Text] [Related]
7. [The problem of appearance of mouse mammary carcinoma]. RIABININA ZA Biull Eksp Biol Med; 1958 Sep; 46(9):105-7. PubMed ID: 13607542 [No Abstract] [Full Text] [Related]
8. Further studies on metastasis of a transplantable mouse mammary carcinoma after roentgen irradiation. VON ESSEN CF; KAPLAN HS J Natl Cancer Inst; 1952 Feb; 12(4):883-92. PubMed ID: 14908552 [No Abstract] [Full Text] [Related]
9. [Inverse effects of hyaluronidase and antihyaluronidase serum on the development of mammary carcinoma in the mouse]. LACASSAGNE A; LOISELEUR J; RUDALI G C R Hebd Seances Acad Sci; 1957 Mar; 244(12):1587-9. PubMed ID: 13427227 [No Abstract] [Full Text] [Related]
10. Expression of gicerin enhances the invasive and metastatic activities of a mouse mammary carcinoma cell line. Tsukamoto Y; Sakaiuchi T; Hiroi S; Furuya M; Tsuchiya S; Sasaki F; Miki N; Taira E Int J Oncol; 2003 Dec; 23(6):1671-7. PubMed ID: 14612940 [TBL] [Abstract][Full Text] [Related]
11. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908 [TBL] [Abstract][Full Text] [Related]
12. [Significance of typological characteristics of the higher nervous activity in the appearance and development of mouse mammary carcinoma]. MALIUGINA LL; MIRONOVA AI; FEDOROV VK; SHABAD LM Biull Eksp Biol Med; 1958 Jun; 45(6):85-9. PubMed ID: 13560552 [No Abstract] [Full Text] [Related]
13. [Various aspects of a mouse mammary tumor associated with different chick embryo organs in culture in vitro]. WOLFF E; SIGOTMF C R Seances Soc Biol Fil; 1961; 155():960-2. PubMed ID: 14007997 [No Abstract] [Full Text] [Related]
14. Effects of roentgen irradiation on the tumor bed. I. The inhibiting action of local pretransplantation roentgen irradiation (1500 r alpha) on the growth of mouse mammary carcinoma. STENSTROM KW; VERMUND H; MOSSER DG; MARVIN JF Radiat Res; 1955 Apr; 2(2):180-91. PubMed ID: 14372038 [No Abstract] [Full Text] [Related]
15. Comparison of the responses of normal, precancerous, and neoplastic mouse mammary tissues to hormones in vitro. ELIAS JJ; RIVERA E Cancer Res; 1959 Jun; 19(5):505-11. PubMed ID: 13663038 [No Abstract] [Full Text] [Related]
16. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253 [TBL] [Abstract][Full Text] [Related]
17. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer. Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874 [TBL] [Abstract][Full Text] [Related]
19. Primary vaginal adenosarcoma with sarcomatous overgrowth. Toyoshima M; Akahira J; Moriya T; Hayakawa S; Yaegashi N Gynecol Oncol; 2004 Dec; 95(3):759-61. PubMed ID: 15582000 [TBL] [Abstract][Full Text] [Related]
20. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Gallardo A; Prat J Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]